Proteomics International Opens Up to $5 Million Share Purchase Plan
PIQ: $0.098 +3.16% · MC: $16M
Proteomics International Laboratories has opened the share purchase plan announced earlier this week, seeking up to $5 million before costs, with discretion to accept oversubscriptions. The target is equivalent to roughly a quarter of its recently observed $20 million market capitalisation. Eligible shareholders can subscribe at $0.10 per share and receive a free option for each share, subject to shareholder approval. The company says the proposed raise is expected to support operations until October 2027 and fund commercialisation, including the planned PromarkerEndo launch and US market preparations.

Comments